ConductScience.org, home
Cell lines
API referenceFor AI assistants

Cell line · CVCL_2063

HCC827

Cancer cell line, Homo sapiens. Lung adenocarcinoma. 122 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. HCC827. Cell lines, record CVCL_2063. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_2063

On this page

Cell line

As Cellosaurus gives it.

Name
HCC827
Accession
CVCL_2063
RRID
RRID:CVCL_2063
Synonyms
HCC-827, HCC 827, HCC0827, HCC827-P, Hamon Cancer Center 827
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
39Y
Category
Cancer cell line
Diseases
Lung adenocarcinoma (NCIt C3512)
Derived from
Lung (in situ)
Entry created
2012-04-04
Entry updated
2026-03-31

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers122

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
HSAT3 lncRNA regulates replication re-initiation and colocalizes with TOP2A under stress conditions.Epigenetics Chromatin2026Its Methods give the RRID and name the linePubMed
Longitudinal Assessment of EGFR and MET Transcriptional Activity Using Cell-Free Chromatin Immunoprecipitation in Two Patients with EGFR-Mutated Non-Small Cell Lung Cancer.Cancers (Basel)2026Its Methods give the RRID and name the linePubMed
JI017 Sensitizes EGFR-T790M NSCLC to Erlotinib by Extinguishing the STAT3-Survivin Axis.Integr Cancer Ther2026Its Methods give the RRID and name the linePubMed
LncRNA MNX1-AS1 drives the progression of non-small cell lung cancer and serves as a ceRNA to target COMMD8 by sponging miR-218-5p.J Mol Histol2026Its Methods give the RRID and name the linePubMed
A USP15/KRT17-associated 13-gene prognostic cluster and functional validation in EGFR-mutant lung adenocarcinoma.Respir Res2026Its Methods give the RRID and name the linePubMed
Discovery of XNW5004 as a novel EZH2 inhibitor that enhances anti-tumor immunity and synergizes with PD-1 blockade immunotherapy in lung adenocarcinoma.J Transl Med2026Its Methods give the RRID and name the linePubMed
Engineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8+ T-cell activation.BMC Med2026Its Methods give the RRID and name the linePubMed
Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in NSCLC.Cell Oncol (Dordr)2026Its Methods give the RRID and name the linePubMed
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer Cells.Cells2026Its Methods give the RRID and name the linePubMed
GPNMB-ECD drives acquired resistance to osimertinib in NSCLC via inducing tumor cell cytoskeletal reorganization.Cell Mol Biol Lett2026Its Methods give the RRID and name the linePubMed

1 to 10 of 122

See all 122 papers

Relatives40

RelationCell lineAccessionProblemSource
Derived from itHCC827 BIRCVCL_E4DKCell lines
Derived from itHCC827 ER1CVCL_EJ07Cell lines
Derived from itHCC827 ER2CVCL_EJ08Cell lines
Derived from itHCC827 ER3CVCL_EJ09Cell lines
Derived from itHCC827 ER4CVCL_EJ10Cell lines
Derived from itHCC827 ER5CVCL_EJ11Cell lines
Derived from itHCC827 GR1CVCL_V620Cell lines
Derived from itHCC827 GR2CVCL_V621Cell lines
Derived from itHCC827 GR5CVCL_V622Cell lines
Derived from itHCC827 GR6CVCL_V623Cell lines

1 to 10 of 40

See all 40 relatives

Cell banks7

Cell bankCatalog numberStatusSource
ATCCCRL-2868ATCC
BCRJ0351BCRJ
CLS305041CLS
DSMZACC-566DSMZ
HysigenTCH-C182Hysigen
KCLB70827KCLB
UbigeneYC-C043Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_2063

GET https://conductscience.org/api/cell-lines/v1/CVCL_2063/papers?page=2

API referenceFor AI assistants